FDA chief renews push for specialty pharmacy rules

December 19, 2012

(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest in cooperating with the agency.

FDA Commissioner Margaret Hamburg met with state pharmacy regulators Wednesday to discuss ways to tighten oversight of compounding pharmacies like the New England Compounding Center.

Contaminated injections from the Framingham, Mass.-based company have been blamed for an outbreak of that has killed 39 people and sickened 620.

Hamburg said federal and state health inspectors need to cooperate more closely to oversee the compounding pharmacies, which fall into a legal gray area between state and federal laws.

Explore further: FDA chief seeks new powers to police pharmacies


Related Stories

FDA chief seeks new powers to police pharmacies

November 14, 2012

(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Senate questions pharmacy boards after outbreak

November 19, 2012

(AP)—A Senate committee investigating a deadly outbreak of meningitis wants to know how regulators in all 50 states oversee specialty pharmacies like the one that triggered the illness.

Congress investigating compounding trade group

December 7, 2012

(AP)—House lawmakers are investigating whether the industry group for compounding pharmacies coached the company responsible for a deadly outbreak of meningitis in dealing with regulators.

Consumer watchdog asks FDA to revisit compounders

November 29, 2012

(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...

FDA chief will testify at first meningitis hearing

November 5, 2012

(AP)—House lawmakers investigating a nationwide outbreak of deadly meningitis are asking the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.

Recommended for you

Does it matter how long you sit—if you are fit?

October 19, 2016

More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes. Some studies have estimated that being ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.